| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0082 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |